Age of eradication and failure rates of clarithromycin-containing triple therapy for Helicobacter pylori: A 15-year population-based study.

Jiang, Fang; Guo, Chuan-Guo; Cheung, Ka Shing; Li, Bofei; Law, Simon Y K; Leung, Wai K

Jiang, Fang; Guo, Chuan-Guo; Cheung, Ka Shing; Li, Bofei; Law, Simon Y K; Leung, Wai K.

Jiang F; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Guo CG; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Cheung KS; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Li B; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Law SYK; Department of Surgery, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Leung WK; Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Helicobacter ; 27(3): e12893, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35411663

Asunto(s)

Infecciones por Helicobacter; Helicobacter pylori; Adolescente; Adulto; Anciano; Amoxicilina/uso terapéutico; Antibacterianos/uso terapéutico; Claritromicina/uso terapéutico; Estudios de Cohortes; Quimioterapia Combinada; Femenino; Infecciones por Helicobacter/tratamiento farmacológico; Humanos; Metronidazol/uso terapéutico; Estudios Retrospectivos

Palabras clave

Helicobacter pylori; age; birth-cohort effect; time trend

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google